Detalhe da pesquisa
1.
Low Hepatitis B Core-Related Antigen Levels Correlate Higher Spontaneous Seroclearance of Hepatitis B Surface Antigen in Chronic Hepatitis B Patients With High Hepatitis B Surface Antigen Levels.
Gastroenterology
; 164(4): 669-679.e6, 2023 04.
Artigo
Inglês
| MEDLINE | ID: mdl-36642151
2.
Metabolic Dysfunction-Associated Steatotic Liver Disease Facilitates Hepatitis B Surface Antigen Seroclearance and Seroconversion.
Clin Gastroenterol Hepatol
; 22(3): 581-590.e6, 2024 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-37871842
3.
Pre-existing and new-onset metabolic dysfunctions increase cirrhosis and its complication risks in chronic hepatitis B.
Am J Gastroenterol
; 2024 Jun 26.
Artigo
Inglês
| MEDLINE | ID: mdl-38920306
4.
Comparison of diagnostic performance among Abbott RealTime HCV Genotyping II, Abbott HCV Genotype plus RUO, and Roche Cobas HCV Genotyping assays for hepatitis C virus genotyping.
J Med Virol
; 96(5): e29686, 2024 May.
Artigo
Inglês
| MEDLINE | ID: mdl-38767142
5.
Four weeks of off-treatment follow-up is sufficient to determine virologic responses at off-treatment week 12 in patients with hepatitis C virus infection receiving fixed-dose pangenotypic direct-acting antivirals.
J Med Virol
; 96(5): e29675, 2024 May.
Artigo
Inglês
| MEDLINE | ID: mdl-38746997
6.
Tenofovir versus entecavir on recurrence and mortality of hepatitis B virus-related hepatocellular carcinoma after curative therapy.
J Formos Med Assoc
; 2024 Feb 28.
Artigo
Inglês
| MEDLINE | ID: mdl-38423922
7.
Metformin reduces hepatocellular carcinoma incidence after successful antiviral therapy in patients with diabetes and chronic hepatitis C in Taiwan.
J Hepatol
; 78(2): 281-292, 2023 02.
Artigo
Inglês
| MEDLINE | ID: mdl-36208843
8.
Long-term Evolution of Estimated Glomerular Filtration Rate in Patients With Antiviral Treatment for Hepatitis C Virus Infection.
Clin Gastroenterol Hepatol
; 21(2): 424-434.e5, 2023 02.
Artigo
Inglês
| MEDLINE | ID: mdl-35131346
9.
Serial increase and high alpha-fetoprotein levels predict the development of hepatocellular carcinoma in 6 months.
Hepatol Res
; 53(10): 1021-1030, 2023 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-37291079
10.
Serum cytokine profiles predict outcomes of chronic hepatitis B patients discontinuing entecavir or tenofovir therapy.
J Formos Med Assoc
; 122(7): 564-573, 2023 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-36872131
11.
Long-term durability of sustained virologic response for hepatitis C virus infection in solid organ transplant recipients receiving direct-acting antivirals.
J Formos Med Assoc
; 122(8): 800-804, 2023 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-36941177
12.
Pre-operative gamma-glutamyl transferase levels predict outcomes in hepatitis B-related hepatocellular carcinoma after curative resection.
J Formos Med Assoc
; 122(10): 1008-1017, 2023 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-37147239
13.
Sofosbuvir/velpatasvir with or without low-dose ribavirin for patients with chronic hepatitis C virus infection and severe renal impairment.
Gut
; 71(1): 176-184, 2022 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33408122
14.
Impact of Sofosbuvir-Based Direct-Acting Antivirals on Renal Function in Chronic Hepatitis C Patients With Impaired Renal Function: A Large Cohort Study From the Nationwide HCV Registry Program (TACR).
Clin Gastroenterol Hepatol
; 20(5): 1151-1162.e6, 2022 05.
Artigo
Inglês
| MEDLINE | ID: mdl-34333150
15.
Hepatitis B Core-Related Antigen Stratifies the Risk of Liver Cancer in HBeAg-Negative Patients With Indeterminate Phase.
Am J Gastroenterol
; 117(5): 748-757, 2022 05 01.
Artigo
Inglês
| MEDLINE | ID: mdl-35191399
16.
Serum cytokine/chemokine profiles predict hepatitis B reactivation in HBV/HCV co-infected subjects receiving direct-acting antiviral agents.
J Formos Med Assoc
; 121(5): 920-929, 2022 May.
Artigo
Inglês
| MEDLINE | ID: mdl-34538552
17.
Serum PIVKA-II and alpha-fetoprotein at virological remission predicts hepatocellular carcinoma in chronic hepatitis B related cirrhosis.
J Formos Med Assoc
; 121(3): 703-711, 2022 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-34452785
18.
Prothrombin induced by vitamin K absence or antagonist-II (PIVKA-II) predicts complete responses of transarterial chemoembolization for hepatocellular carcinoma.
J Formos Med Assoc
; 121(8): 1579-1587, 2022 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-35078686
19.
Ledipasvir/sofosbuvir for HCV genotype 1, 2, 4-6 infection: Real-world evidence from a nationwide registry in Taiwan.
J Formos Med Assoc
; 121(8): 1567-1578, 2022 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-35123849
20.
Ledipasvir/Sofosbuvir for 8, 12, or 24 Weeks in Hepatitis C Patients Undergoing Dialysis for End-Stage Renal Disease.
Am J Gastroenterol
; 116(9): 1924-1928, 2021 09 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34465694